| Date | Title | Description |
| 15.08.2026 | What investors say went wrong at Selena Gomez's mental health startup Wondermind | Selena Gomez set out to create "the world's first mental fitness ecosystem." Instead, the startup is becoming her own personal headache.
A federal lawsuit filed Thursday offers a detailed account of what investors say went wrong a... |
| 07.08.2026 | Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette | Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette
Fri, Aug 07, 2026 17:35 CET Report this content
New Strategic Advisory Board supports Wellspect HealthCare’s next phase of growth, wi... |
| 06.07.2026 | Founder Olive Tai Appointed Chairman of the Board of Synagistics; John Wu Appointed Chief Executive Officer as Company Enters Next Stage of AI and Digital Commerce Growth | HONG KONG, July 6, 2026 /PRNewswire/ -- Synagistics Limited ("Synagistics", Stock code: 2562.HK), a Singapore-based AI, big data and digital commerce company listed on the Main Board of The Stock Exchange of Hong Kong Limited, tod... |
| 23.06.2026 | Diamond Packaging Introduces Recipe for American Craft™ Collection Inspired by 250 Years of American Innovation | Limited-edition collection showcases packaging decoration techniques through iconic American imagery.
ROCHESTER, N.Y., June 23, 2026 /PRNewswire-PRWeb/ -- Diamond Packaging today announced the launch of Recipe for American Craft™, a limited... |
| 17.06.2026 | Emmecell Closes Funding | Emmecell, a Menlo Park, CA-based clinical-stage biotechnology company developing magnetic cell delivery technologies for ophthalmic diseases, raised an undisclosed amount in funding.
Backers included both existing investors and Bausch + Lom... |
| 16.06.2026 | Emmecell Closes Strategic Financing To Advance Magnetic Cell Delivery Platform For Ophthalmic Diseases | Emmecell, a clinical-stage biotechnology company developing magnetic cell delivery technologies for ophthalmic diseases, announced the successful closing of a strategic financing round. The financing included participation from existing inv... |
| 20.05.2026 | Better Futures raises €600k to automate engineering documentation process | Better Futures, the Irish AI company automating engineering documentation in regulated industries, has secured €600,000 in funding from private angel investors and Enterprise Ireland.
The NovaUCD-based firm has now raised €1.1m to date, and... |
| 06.05.2026 | Automatic Fire to add 100 jobs following Cardinal Capital investment | Private equity group Cardinal Capital has made a significant investment in Automatic Fire, the independent fire-protection firm.
The investment will support Park West-based Automatic Fire's ambitious growth programme, which will see the com... |
| 07.04.2026 | Corporate Vision and Trade Confrontation: The Shifting U.S. Economic Narrative | Motorola Solutions CEO Greg Brown earns top honors, lauded for transforming the company into a global public safety and security technology leader. His strategic vision and operational prowess drove exceptional growth and innovation. Meanwh... |
| 06.04.2026 | Motorola Solutions' Greg Brown Is Chief Executive Magazine's 2026 CEO of the Year | Chief Executive magazine announced Motorola Solutions Chairman and CEO Greg Brown as 2026 Chief Executive of the Year, recognizing his leadership in transforming the company into a leading safety and security technology provider and deliver... |
| 20.10.2025 | Activist investor Jana Partners takes stake in medical device maker Cooper Companies, WSJ says | Activist investor Jana Partners has taken a stake in medical device maker Cooper Cos. and will push the firm to explore strategic options, The Wall Street Journal reported Monday.
Shares of Cooper were up 4% in afternoon trading Monday.
The... |
| 07.10.2025 | Collaborations Pharmaceuticals, Inc., Partners with Bausch + Lomb to Publish Research on Advancing AI Drug Development | Mega eye logo
Collaborations Pharmaceuticals logo RALEIGH, NC, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Collaborations Pharmaceuticals, Inc. (CPI) has partnered with Bausch + Lomb to build and validate an array of artificial int... |
| 18.09.2025 | Character Biosciences Expands Series B Extension | Character Biosciences, Jersey City, NJ-based precision medicine company, raised an undisclosed amount in Series B extension.
Backers included Sanofi Ventures.
The company intends to use the funds to further advance the clinical development ... |
| 07.08.2025 | Samba TV: 68% of Top Brands Boosted TV Ad Spend in H1 2025 | Samba TV, the global leader in AI-driven media intelligence, today released its H1 2025 State of Advertising report revealing a clear signal of advertiser strength with 68% of the top 100 advertisers increasing their TV spend in the first h... |
| 05.08.2025 | Planet Possible: 2025 Sustainability Awards Reveal the Changemakers Turning Green Goals into Bottom‑Line Growth | 2025 Sustainability Awards honor companies, products & leaders driving growth through ESG innovation, proving purpose-driven strategies can power profit and planet progress.
PHILADELPHIA, Aug. 5, 2025 /PRNewswire-PRWeb/ -- The Business ... |
| 08.04.2025 | Arena AI raises $30M to accelerate innovation in hardware testing with Atlas
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to prov... | Arena Technologies Inc., the developer of a cutting-edge artificial intelligence platform for hardware testing and optimization, today announced it has raised $30 million in early-stage funding to scale the development of Atlas, the company... |
| 08.04.2025 | Diamond Packaging Earns EcoVadis Platinum Rating for the Third Time, Setting the Industry Standard in Sustainability | EcoVadis rating validates Diamond's business sustainability commitments and performance.
ROCHESTER, N.Y., April 8, 2025 /PRNewswire-PRWeb/ -- Diamond Packaging announced today it has been awarded a Platinum rating for the third time by EcoV... |
| 07.04.2025 | Lilly's Dave Ricks Named Chief Executive Magazine's 2025 CEO of the Year | Dave Ricks, CEO of Eli Lilly and Company, has been named Chief Executive Magazine's 2025 Chief Executive of the Year by his peer CEOs.
Chief Executive magazine today announced Dave Ricks, CEO of Eli Lilly and Company, has been named 2025 Ch... |
| 07.04.2025 | Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses in the U.S. | COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement
Summary
Comp... |
| 31.03.2025 | Character Biosciences: Pioneering Precision Medicine for Eye Diseases | In the realm of healthcare, precision medicine is the compass guiding us toward targeted therapies. Character Biosciences, a New Jersey-based company, is at the forefront of this revolution. Recently, they secured a hefty $93 million in Ser... |
| 28.03.2025 | Stocks making the biggest moves midday: Rocket Lab, Lululemon, AppLovin, Bausch + Lomb and more | - |
| 28.03.2025 | Character Biosciences: $93 Million (Series B) Secured For Advancing Precision Medicine For Progressive Eye Diseases | Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, announced an oversubscribed $93 million Series B financing round to accelerate the advancement of its pipeline of precision therapies ... |
| 01.03.2025 | Junevity: Pioneering the Future of Longevity with $10 Million Seed Funding | In the bustling heart of San Francisco, a biotechnology company named Junevity is making waves. With a mission to extend both lifespan and healthspan, Junevity has successfully raised $10 million in seed funding. This financial boost, led b... |
| 27.02.2025 | Junevity: $10 Million (Seed) Raised For Developing Cell Reset Therapeutics For Longevity | Junevity – a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related diseases – announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.
Junevity’s RESET plat... |
| 14.02.2025 | Junevity: $10 Million (Seed) Raised For Developing Cell Reset Therapeutics For Longevity | Junevity, a biotechnology company that aims to extend lifespan and health by resetting cell damage from age-related diseases, announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.
The Junevity RESET platform is... |
| 13.02.2025 | HowNow's £7.5M Series A: A Leap into the Future of Learning | In the bustling streets of London, a quiet revolution is brewing. HowNow, an edtech startup, has secured £7.5 million in Series A funding. This investment is not just a financial boost; it’s a ticket to reshape the learning landscape. HowNo... |
| 12.02.2025 | London-based edtech HowNow raises £7.5m Series A | AI-powered learning and skills platform HowNow has completed its Series A funding having raised a total of £7.5M. The round was led by Mercia Ventures and Pearson in February 2023, following previous investment from the two in 2023.
Headqua... |
| 09.01.2025 | Collaborations Pharmaceuticals, Inc., and Bausch + Lomb Bring Artificial Intelligence to Ocular Drug Discovery | Collaborations Pharmaceuticals logo
Collaborations Pharmaceuticals, Inc., and Bausch + Lomb Work Together to Bring Artificial Intelligence to Ocular Drug Discovery RALEIGH, NC, UNITED STATES, January 9, 2025 /EINPresswire.com/ -- Collaborat... |
| 30.12.2024 | Winners Announced in the 14th Annual Best in Biz Awards | Winning entries showcase visionary innovation and cutting-edge applications of AI, exemplary workplace practices, and a continued focus on environmental responsibility
NEW YORK, Dec. 30, 2024 /PRNewswire-PRWeb/ -- Best in Biz Awards, the on... |
| 11.12.2024 |
Bausch + Lomb acquires glaucoma treatment company Elios Vision | Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery (MIGS) procedure.
The Elios procedure uses an excimer laser to treat glaucoma in conjunction with cataract surgery wit... |
| 07.12.2024 | Выбор однодневных контактных линз 2024 | Вступление
Я ношу очки с 11 лет, то есть примерно с 1997 года. Ничего особенного или специфического, просто миопия -4.5 на оба глаза. В те времена не было даже мысли, что можно как-то решать проблему не только с помощью очков.
Однако пример... |
| 14.11.2024 | Winners of 2024 New York ORBIE Awards Announced By NewYorkCIO | Executives from Morgan Stanley, Intel Corporation, MUFG Bank Ltd, Johnson & Johnson, Crum & Forster - Surplus & Specialty, United Nations Federal Credit Union, Bausch + Lomb & Major League Baseball Recognized for their Achie... |
| 23.10.2024 | Horizon Surgical Systems: A New Dawn in Microsurgery | In the heart of Malibu, a revolution is brewing. Horizon Surgical Systems, a micro-robotics company, has secured $30 million in Series A funding. This isn’t just another investment; it’s a leap into the future of surgery. The funding round ... |
| 22.10.2024 | Horizon Surgical Systems: Micro-Robotics Company Raises $30 Million (Series A) | Horizon Surgical Systems, a privately held micro-robotics company advancing microsurgery with automated AI-enabled robotics, announced the closing of a $30 million Series A financing. The funding was led by ExSight Ventures and a major corp... |
| 27.08.2024 | ENDO ANNOUNCES CEO TRANSITION | Board to Initiate CEO Search Process; Scott Hirsch Appointed as Interim CEO
MALVERN, Pa., Aug. 27, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company t... |
| 25.06.2024 | Private Advisor Group Welcomes Delisanti Wealth Management | MORRISTOWN, N.J., June 25, 2024 /PRNewswire/ -- Private Advisor Group, one of the largest and fastest-growing independent wealth management firms in the country*, welcomes Delisanti Wealth Management. Led by Owner and President, Robb Delisa... |
| 21.04.2024 | Predicting the Next Breakthroughs in Eye Care Technology | - |
| 08.04.2024 | Did you look at the solar eclipse too long? Doctors explain signs of eye damage | Did you look up at the solar eclipse without your safety glasses? Looking at the sun — even when it's partially covered like during the eclipse on April 8 — can cause eye damage.
There is no safe dose of solar ultraviolet rays or infrared r... |
| 08.04.2024 | Why is looking at a solar eclipse dangerous without special glasses? Eye doctors explain. | The solar eclipse will be visible for millions of Americans on April 8, 2024, making many excited to see it — but how you watch it matters, since it can be dangerous for your eyes.
A solar eclipse occurs when the moon passes between the sun... |
| 07.04.2024 | How to make solar eclipse glasses, cereal box viewers and pinhole cameras to watch the 2024 show safely | If you can't get your hands on a pair of solar eclipse glasses, experts say there are still ways to enjoy the event safely.
There are also unsafe alternatives, including wearing your normal sunglasses — or even stacking two or three.
"... |
| 25.03.2024 | NaturVet teases new breed-specific supplements | ORLANDO, FLA. — NaturVet exhibited its latest product advancements during Global Pet Expo from March 20 to 22. The brand showcased new vet-formulated dog supplements under its Breed Specific Soft Chew® line, as well as its Scoopables® colle... |
| 12.03.2024 | Global Intraocular Lens Market Projected to Reach USD 6 Billion by 2029 with CAGR of 6.3% | - |
| 12.03.2024 | Global Ophthalmic Eye Droppers Market Report 2024: A $25.88 Billion Opportunity by 2034 with Regional and Country-Level Data for Types, Drugs, Treatments, and End-users | - |
| 07.03.2024 | Dr. Kent Wellish Successfully Implants First Bausch + Lomb Toric Aspire "Range of Vision" IOL in Las Vegas | American Vision Partners
Dr. Kent Wellish of Wellish Vision Institute, an affiliate of American Vision Partners, has achieved a significant milestone in the field of ophthalmology by successfully implanting the first Bausch + Lomb Toric Asp... |
| 19.01.2023 | Bausch + Lomb Acquires AcuFocus | Bausch + Lomb (NYSE/TSX: BLCO), a Vaughan, Ontario and Bridgewater, NJ-based health company, acquired AcuFocus, Inc., an Irvine, CA-based ophthalmic medical device company.
The amount of the deal was not disclosed.
With the acquisition, Bau... |
| 28.04.2022 | Bausch + Lomb Targets $8.4 Billion Valuation with IPO | Bausch + Lomb Corp., the eye-health unit of Bausch Health Companies Inc , is going public next week.
On Thursday, Bausch + Lomb set terms for its initial public offering. The company, based in Vaughan, Ontario, Canada, plans to sell 35 mill... |
| 14.01.2022 | Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three | Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has filed preliminary paperwork for an IPO, a ... |
| 09.02.2021 | Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea | |
| 02.10.2017 | IEA Shortlists Ireland's Best SME Exporters | The Irish Exporters Association has shortlisted 59 businesses for the 17th Export Industry Awards. Eleven category winners and one overall ‘Exporter of the Year’ will be announced at the black-tie awards ceremony on Friday, November 17, at ... |
| 07.06.2017 | Term Sheet — Wednesday, June 7 | 500
Hello, it’s Fortune 500 day! The 2017 list is live here. For 63 years, this list has ranked the largest companies in the U.S. by revenue.
Paid Content You can't secure what you can't see From ExtraHop
KKR got rather dramatically knocked... |
| 15.04.2013 | Bausch + Lomb laser device wins new approvals in Europe | Bausch + Lomb won new CE Mark approvals for its Victus laser platform, allowing the device maker to market the system for additional uses during cataract surgery.
In additional to corneal incision, European regulators approved 2 additional ... |
| 30.11.2011 | AcuFocus Closes $65M Financing | AcuFocus, Inc., an Irvine, California-based developer of an innovative corneal inlay for the treatment of near vision loss (presbyopia), closed a $65m financing.
The round was led by Cowen Healthcare Royalty Partners, with participation fro... |
| 21.01.2008 | Life sciences briefing: Monday, Jan. 21, 2008 | TODAY’S HEADLINES:
Joint-implant maker Ascension Orthopedics raises $21M (release)
High-speed sequencer Genome Corp. draws another $250K (GenomeWeb News)
Bausch & Lomb acquires implantable lens maker Eyeonics (release)
Bederra buys up H... |
| - | Bausch + Lomb valued at US$6.5 billion after stock ticks up in NYSE debut | Bausch + Lomb was valued at US$6.48 billion in its US market debut on Friday (May 6) as the eye-care company's shares opened nearly 3 per cent above an offer price that was well below the targeted range.
The modest reception from investors ... |
| - | Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three | Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has filed preliminary paperwork for an IPO, a ... |
| - | Bausch + Lomb eyes over $8 billion valuation in IPO amid slowdown for listings | By Mehnaz Yasmin and Noor Zainab Hussain
(Reuters) -Eye care products maker Bausch + Lomb on Thursday sought a valuation of as much $8.4 billion for its flotation in the U.S. and Canada, as it looks to test the appetite of capital markets i... |
